Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 37.06% is 232% above its 5-year average of -28.01%, near the high end of its 5-year range (-711.99%–55.68%).
16.26% below its 12-month average of 44.25%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 55.68%.
OPERATING MARGIN
37.06%
OPERATING MARGIN AVG TTM
44.25%
OPERATING MARGIN AVG 3Y
8.64%
OPERATING MARGIN AVG 5Y
-28.01%
OPERATING MARGIN AVG 10Y
-17600.64%
OPERATING MARGIN AVG 15Y
-2932.33%
OPERATING MARGIN AVG 20Y
-2325.99%
CURRENT VS TTM AVG
-16.26%
CURRENT VS 3Y AVG
+329.09%
CURRENT VS 5Y AVG
+232.33%
CURRENT VS 10Y AVG
+100.21%
CURRENT VS 15Y AVG
+101.26%
CURRENT VS 20Y AVG
+101.59%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 501 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aurinia Pharmaceuticals Inc.
Market Cap
$2.02B
Operating Margin
37.06%
TTM Avg
44.25%
3Y Avg
8.64%
5Y Avg
-28.01%
Market Cap
$2.02B
Operating Margin
-3084.76%
TTM Avg
-3233.57%
3Y Avg
-1812.12%
5Y Avg
-1208.08%
Market Cap
$2.01B
Operating Margin
0.41%
TTM Avg
-3.56%
3Y Avg
0.15%
5Y Avg
-1.31%
Market Cap
$2.00B
Operating Margin
-5.12%
TTM Avg
-2.62%
3Y Avg
-10.04%
5Y Avg
-13.46%
Market Cap
$2.05B
Operating Margin
6.02%
TTM Avg
5.04%
3Y Avg
-2.01%
5Y Avg
-12.30%
Market Cap
$2.06B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$1.96B
Operating Margin
-18.48%
TTM Avg
-24.30%
3Y Avg
-28.12%
5Y Avg
-27.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.02B | 37.06% | 44.25% | 8.64% | -28.01% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -3084.76% | -3233.57% | -1812.12% | -1208.08% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | 0.41% | -3.56% | 0.15% | -1.31% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -5.12% | -2.62% | -10.04% | -13.46% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 6.02% | 5.04% | -2.01% | -12.30% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.06B | 38.98% | 19.21% | -11.92% | -190.31% |
| Alvotech (ALVO)vs › | $2.07B | 9.62% | 13.78% | -194.45% | -270.76% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -3.49% | -3.57% | -5.95% | -5.03% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -18.48% | -24.30% | -28.12% | -27.55% |
| Absci Corporation (ABSI)vs › | $1.95B | -4454.21% | -3427.90% | -2683.37% | -2097.52% |
Gross Margin
90.4%
Operating Margin
37.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 55.68% |
| 2026-03-31 | 53.31% |
| 2025-12-31 | 43.10% |
| 2025-09-30 | 40.49% |
| 2025-06-30 | 28.69% |
| 2025-03-31 | 34.97% |
| 2024-12-31 | -2.79% |
| 2024-09-30 | 17.33% |
| 2024-06-30 | -2.65% |
| 2024-03-31 | -21.26% |
| 2023-12-31 | -65.80% |
| 2023-09-30 | -29.83% |
| 2023-06-30 | -38.97% |
| 2023-03-31 | -85.98% |
| 2022-12-31 | -98.82% |
| 2022-09-30 | -17.03% |
| 2022-06-30 | -127.66% |
| 2022-03-31 | -175.18% |
| 2021-12-31 | -139.74% |
| 2021-09-30 | -343.31% |
| 2021-06-30 | -711.99% |
| 2021-03-31 | -5529.87% |
| 2020-12-31 | -16.09% |
| 2020-09-30 | -145913.79% |
| 2020-06-30 | -92631.03% |
| 2020-03-31 | -90200.00% |
| 2019-12-31 | -72068.97% |
| 2019-09-30 | -10439.57% |
| 2019-06-30 | -56737.93% |
| 2019-03-31 | -49616.67% |
| 2018-12-31 | -50562.07% |
| 2018-09-30 | -3762.13% |
| 2018-06-30 | -49448.28% |
| 2018-03-31 | -43490.00% |
| 2017-12-31 | -39158.06% |
| 2017-09-30 | -47551.72% |
| 2017-06-30 | -3054.41% |
| 2017-03-31 | -35758.06% |
| 2016-12-31 | -26750.00% |
| 2016-09-30 | -17387.10% |
| 2016-06-30 | -8276.36% |
| 2016-03-31 | -8503.51% |
| 2015-12-31 | -9691.23% |
| 2015-09-30 | -11277.19% |
| 2015-06-30 | -10257.63% |
| 2015-03-31 | -8993.55% |
| 2014-12-31 | -7119.12% |
| 2014-09-30 | -5847.22% |
| 2014-06-30 | -6433.80% |
| 2014-03-31 | -5556.72% |
| 2013-12-31 | -194.72% |
| 2013-09-30 | -1206.91% |
| 2013-06-30 | -1091.95% |
| 2013-03-31 | -933.71% |
| 2012-12-31 | -6547.08% |
| 2012-09-30 | -1934.89% |
| 2012-06-30 | -2158.91% |
| 2012-03-31 | 65.17% |
| 2011-12-31 | -1561.21% |
| 2011-09-30 | -207.21% |
| 2011-06-30 | -1247.30% |
| 2011-03-31 | -1300.75% |
| 2010-12-31 | -703.29% |
| 2010-09-30 | -533.83% |
| 2010-06-30 | -43.36% |
| 2010-03-31 | -64.23% |
| 2009-12-31 | -103.26% |
| 2009-09-30 | -182.16% |
| 2009-06-30 | -375.21% |
| 2009-03-31 | -400.24% |
| 2008-12-31 | -2344.85% |
| 2008-09-30 | -139.32% |
| 2008-06-30 | -1003.54% |
| 2008-03-31 | -921.93% |
| 2007-12-31 | -1480.80% |
| 2007-09-30 | -1472.55% |
| 2007-06-30 | -2274.40% |
| 2007-03-31 | -1167.67% |
| 2006-12-31 | -958.53% |
| 2006-09-30 | -1284.83% |
| 2006-06-30 | -660.92% |
| 2006-03-31 | -356.89% |
| 2005-12-31 | 845.24% |
| 2005-09-30 | -321.46% |
| 2005-06-30 | -3412.02% |
| 2005-03-31 | -2306.77% |
| 2004-12-31 | -3409.49% |
| 2004-09-30 | -2543.81% |
| 2004-06-30 | -1565.00% |
| 2004-03-31 | -729.04% |
| 2003-12-31 | -862.94% |
| 2003-09-30 | -1348.68% |
| 2003-06-30 | 27.05% |
| 2003-03-31 | -1498.11% |
| 2002-12-31 | -1029.45% |
| 2002-09-30 | 41.38% |
